Stavudine Capsule

  • Main ingredients
  • Strength
  • Package

Trade name






 Capsule with white powder content.




For the treatment of HIV (human immunodeficiency virus) infection in combination therapy.


Usage and Dosage


The interval of dosing is 12 hours, which is not related with meal.

For adult with bodyweight60 kg, 40 mg per time, 2 times a day; for the adult with bodyweight60 kg, 30mg per time, 2 times a day.

For the child with bodyweight30 kg, 1mg per kg per time, 2 times a day; for the child with bodyweight30 kg, equal to the adult.

Dose Adjustment: If the patients have hand, foot numbness, tingling after taking the drug, attention should be paid to peripheral neuropathy. These symptoms can hardly be found in children. If any of these symptoms appear in the treatment, the stavudine treatment should be immediately terminated and symptoms can disappear, however, in some cases, the symptoms will aggravate. Until the symptoms disappeared completely, the adults could continue using the drug as the following dosages:

Weight60 kg, 20mg/time and twice a day;

Weight<60 kg, 15mg/time and twice a day.

The children dosage will be half.

If neuropathy occurs after continuing using this product, the treatment should be stopped.

Renal insufficiency: see Table III for the dosage of renal dysfunction.


Elimination of creatinineml/min

Recommended dose according to patient weight

≥60 kg

60 kg


40 mg/12hr

30 mg/12hr


20 mg/12hr

15 mg/12hr


20 mg/24hr

15 mg/24hr




(1) 15mg; (2) 20mg




Preserve in a tightly sealed container, stored at a dry place, protected from light.




Pharmaceutical plastic bottle packaging, 15 mg x 60 capsules/bottle, 20 mg x 60 capsules/bottle.


Shelf life


Tentative 18 months